Addendum: Drugs for Chronic Heart Failure

In the recent Medical Letter article on Drugs for Chronic Heart Failure (2025: 67:81), the paragraph on adverse effects of SGLT2 inhibitors should have stated that these drugs can cause ketoacidosis, which can be fatal, especially in patients with type 1 diabetes.

Publication Details

Journal
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Published
2025-07-21
DOI
https://doi.org/10.58347/tml.2025.1733i
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Addendum: Drugs for Chronic Heart Failure

˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Diabetes Treatment and Management
article

Addendum: Drugs for Chronic Heart Failure

article en

Abstract

In the recent Medical Letter article on Drugs for Chronic Heart Failure (2025: 67:81), the paragraph on adverse effects of SGLT2 inhibitors should have stated that these drugs can cause ketoacidosis, which can be fatal, especially in patients with type 1 diabetes.

˜The œmedical letter on drugs and therapeutics/˜The œmedical letterVol. 67(1733)
Good health and well-being
Openalex Percentile: Top 75%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Addendum: Drugs for Chronic Heart Failure · ˜The œmedical letter on drugs and therapeutics/˜The œmedical letter (2025) | TGRS Research Map | TGRS